[
  {
    "company": "CinCor Pharma",
    "ticker": "CINC",
    "date": "2022-01-06",
    "offer": 17,
    "proceeds": 193.6,
    "year": 2022,
    "area": "Cardio/Hypertension",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 11390000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Akoya Biosciences",
    "ticker": "AKYA",
    "date": "2022-01-06",
    "offer": 20,
    "proceeds": 173,
    "year": 2022,
    "area": "General Biotech",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Vaccinex",
    "ticker": "VCNX",
    "date": "2022-01-06",
    "offer": 2.9,
    "proceeds": 12,
    "year": 2022,
    "area": "Immunology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Amylyx Pharmaceuticals",
    "ticker": "AMLX",
    "date": "2022-01-07",
    "offer": 19,
    "proceeds": 190,
    "year": 2022,
    "area": "Neuroscience/ALS",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Vigil Neuroscience",
    "ticker": "VIGL",
    "date": "2022-01-11",
    "offer": 14,
    "proceeds": 98,
    "year": 2022,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 7000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Hillstream BioPharma",
    "ticker": "HILS",
    "date": "2022-01-11",
    "offer": 5,
    "proceeds": 15,
    "year": 2022,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Arcellx",
    "ticker": "ACLX",
    "date": "2022-02-04",
    "offer": 15,
    "proceeds": 142.31,
    "year": 2022,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9490000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Nuvectis Pharma",
    "ticker": "NVCT",
    "date": "2022-02-04",
    "offer": 5,
    "proceeds": 16,
    "year": 2022,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3200000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "TC BioPharmaceuticals",
    "ticker": "TCBP",
    "date": "2022-02-11",
    "offer": 5,
    "proceeds": 18,
    "year": 2022,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3600000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Blue Water Vaccines",
    "ticker": "ONCO",
    "date": "2022-02-17",
    "offer": 9,
    "proceeds": 20,
    "year": 2022,
    "area": "Immunology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Blue Water Vaccines",
    "ticker": "BWV",
    "date": "2022-02-18",
    "offer": 6,
    "proceeds": 20,
    "year": 2022,
    "area": "Vaccines",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3330000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "AN2 Therapeutics",
    "ticker": "ANTX",
    "date": "2022-03-24",
    "offer": 15,
    "proceeds": 69,
    "year": 2022,
    "area": "Infectious Disease",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 4600000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Belite Bio",
    "ticker": "BLTE",
    "date": "2022-04-29",
    "offer": 8,
    "proceeds": 36,
    "year": 2022,
    "area": "Ophthalmology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 4500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "HilleVax",
    "ticker": "HLVX",
    "date": "2022-04-29",
    "offer": 17,
    "proceeds": 200,
    "year": 2022,
    "area": "Vaccines/GI",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 11760000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "PepGen",
    "ticker": "PEPG",
    "date": "2022-05-05",
    "offer": 12,
    "proceeds": 108,
    "year": 2022,
    "area": "Gene Therapy/Neuromuscular",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Bausch + Lomb",
    "ticker": "BLCO",
    "date": "2022-05-06",
    "offer": 18,
    "proceeds": 630,
    "year": 2022,
    "area": "General Biotech",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Okyo Pharma",
    "ticker": "OKYO",
    "date": "2022-05-17",
    "offer": 5,
    "proceeds": 2.5,
    "year": 2022,
    "area": "Ophthalmology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "MAIA Biotechnology",
    "ticker": "MAIA",
    "date": "2022-07-01",
    "offer": 5,
    "proceeds": 6.9,
    "year": 2022,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1380000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "PaxMedica",
    "ticker": "PXMD",
    "date": "2022-08-26",
    "offer": 5.25,
    "proceeds": 8,
    "year": 2022,
    "area": "General Biotech",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Shuttle Pharmaceuticals",
    "ticker": "SHPH",
    "date": "2022-08-30",
    "offer": 8.13,
    "proceeds": 10,
    "year": 2022,
    "area": "General Biotech",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Third Harmonic Bio",
    "ticker": "THRD",
    "date": "2022-09-14",
    "offer": 17,
    "proceeds": 185.3,
    "year": 2022,
    "area": "Immunology/Allergy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10900000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Prime Medicine",
    "ticker": "PRME",
    "date": "2022-10-19",
    "offer": 17,
    "proceeds": 175,
    "year": 2022,
    "area": "Gene Editing",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10290000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Acrivon Therapeutics",
    "ticker": "ACRV",
    "date": "2022-11-14",
    "offer": 12.5,
    "proceeds": 94.38,
    "year": 2022,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 7550000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Coya Therapeutics",
    "ticker": "COYA",
    "date": "2022-12-01",
    "offer": 5,
    "proceeds": 5.75,
    "year": 2022,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1150000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Lipella Pharmaceuticals",
    "ticker": "LIPO",
    "date": "2022-12-19",
    "offer": 5.75,
    "proceeds": 7,
    "year": 2022,
    "area": "General Biotech",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Cadrenal Therapeutics",
    "ticker": "CVKD",
    "date": "2023-01-20",
    "offer": 4,
    "proceeds": 7,
    "year": 2023,
    "area": "Hematology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Genelux",
    "ticker": "GNLX",
    "date": "2023-01-26",
    "offer": 5,
    "proceeds": 15,
    "year": 2023,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Structure Therapeutics",
    "ticker": "GPCR",
    "date": "2023-02-02",
    "offer": 15,
    "proceeds": 161.1,
    "year": 2023,
    "area": "Metabolic/Obesity",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10740000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Mineralys Therapeutics",
    "ticker": "MLYS",
    "date": "2023-02-09",
    "offer": 16,
    "proceeds": 220.8,
    "year": 2023,
    "area": "Cardio/Hypertension",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 13800000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "CytoMed Therapeutics",
    "ticker": "GDTC",
    "date": "2023-04-14",
    "offer": 4,
    "proceeds": 9.64,
    "year": 2023,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2410000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Acelyrin",
    "ticker": "SLRN",
    "date": "2023-05-04",
    "offer": 18,
    "proceeds": 540,
    "year": 2023,
    "area": "Immunology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 30000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Azitra",
    "ticker": "AZTR",
    "date": "2023-06-16",
    "offer": 4,
    "proceeds": 7.5,
    "year": 2023,
    "area": "Dermatology/Microbiome",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1880000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Intensity Therapeutics",
    "ticker": "INTS",
    "date": "2023-06-30",
    "offer": 7,
    "proceeds": 19.5,
    "year": 2023,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2790000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "60 Degrees Pharmaceuticals",
    "ticker": "SXTP",
    "date": "2023-07-12",
    "offer": 4,
    "proceeds": 7.5,
    "year": 2023,
    "area": "Infectious Disease",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1880000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Apogee Therapeutics",
    "ticker": "APGE",
    "date": "2023-07-13",
    "offer": 17,
    "proceeds": 300.5,
    "year": 2023,
    "area": "Immunology/Dermatology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 17680000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Sagimet Biosciences",
    "ticker": "SGMT",
    "date": "2023-07-13",
    "offer": 16,
    "proceeds": 85,
    "year": 2023,
    "area": "Metabolic/NASH",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 5310000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Turnstone Biologics",
    "ticker": "TSBX",
    "date": "2023-07-20",
    "offer": 12,
    "proceeds": 80,
    "year": 2023,
    "area": "Cell Therapy/Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6670000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Mira Pharmaceuticals",
    "ticker": "MIRA",
    "date": "2023-08-03",
    "offer": 4,
    "proceeds": 8.9,
    "year": 2023,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2230000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "RayzeBio",
    "ticker": "RYZB",
    "date": "2023-09-14",
    "offer": 18,
    "proceeds": 311,
    "year": 2023,
    "area": "Oncology/Radiopharm",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 17280000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Neumora Therapeutics",
    "ticker": "NMRA",
    "date": "2023-09-14",
    "offer": 17,
    "proceeds": 250.7,
    "year": 2023,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 14750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Adlai Nortye",
    "ticker": "ANL",
    "date": "2023-09-29",
    "offer": 6.5,
    "proceeds": 97.5,
    "year": 2023,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 15000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Celularity",
    "ticker": "CELU",
    "date": "2023-10-18",
    "offer": 6.66,
    "proceeds": 32,
    "year": 2023,
    "area": "General Biotech",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Abivax",
    "ticker": "ABVX",
    "date": "2023-10-19",
    "offer": 11.6,
    "proceeds": 235.8,
    "year": 2023,
    "area": "GI/Immunology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 20330000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Lexeo Therapeutics",
    "ticker": "LXEO",
    "date": "2023-11-02",
    "offer": 11,
    "proceeds": 100,
    "year": 2023,
    "area": "Gene Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9090000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Cargo Therapeutics",
    "ticker": "CRGX",
    "date": "2023-11-09",
    "offer": 15,
    "proceeds": 281.25,
    "year": 2023,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 18750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Atreca",
    "ticker": "BCEL",
    "date": "2023-12-08",
    "offer": 28.22,
    "proceeds": 42,
    "year": 2023,
    "area": "General Biotech",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "CG Oncology",
    "ticker": "CGON",
    "date": "2024-01-25",
    "offer": 19,
    "proceeds": 380,
    "year": 2024,
    "area": "Oncology/Urology",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 20000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "ArriVent BioPharma",
    "ticker": "AVBP",
    "date": "2024-01-25",
    "offer": 18,
    "proceeds": 175,
    "year": 2024,
    "area": "Oncology",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 9720000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "MindMed",
    "ticker": "MNMD",
    "date": "2024-01-30",
    "offer": 6.09,
    "proceeds": 60,
    "year": 2024,
    "area": "General Biotech",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Alto Neuroscience",
    "ticker": "ANRO",
    "date": "2024-02-01",
    "offer": 16,
    "proceeds": 147.9,
    "year": 2024,
    "area": "Neuroscience/AI",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 9240000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Fractyl Health",
    "ticker": "GUTS",
    "date": "2024-02-01",
    "offer": 15,
    "proceeds": 100,
    "year": 2024,
    "area": "Metabolic/Diabetes",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6670000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Kyverna Therapeutics",
    "ticker": "KYTX",
    "date": "2024-02-07",
    "offer": 22,
    "proceeds": 319,
    "year": 2024,
    "area": "Cell Therapy/Autoimmune",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 14500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Metagenomi",
    "ticker": "MGX",
    "date": "2024-02-08",
    "offer": 15,
    "proceeds": 93.75,
    "year": 2024,
    "area": "Gene Editing",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6250000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Telomir Pharmaceuticals",
    "ticker": "TELO",
    "date": "2024-02-29",
    "offer": 4,
    "proceeds": 7,
    "year": 2024,
    "area": "Anti-aging",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Alpha Tau Medical",
    "ticker": "APTM",
    "date": "2024-03-06",
    "offer": 21.88,
    "proceeds": 58,
    "year": 2024,
    "area": "General Biotech",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Boundless Bio",
    "ticker": "BOLD",
    "date": "2024-03-27",
    "offer": 16,
    "proceeds": 100,
    "year": 2024,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6250000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Crinetics Pharmaceuticals Re-IPO",
    "ticker": "CRNX",
    "date": "2024-03-28",
    "offer": 50.5,
    "proceeds": 350,
    "year": 2024,
    "area": "General Biotech",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Contineum Therapeutics",
    "ticker": "CTNM",
    "date": "2024-04-04",
    "offer": 16,
    "proceeds": 110,
    "year": 2024,
    "area": "Neuroscience/Immunology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6880000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Rapport Therapeutics",
    "ticker": "RAPP",
    "date": "2024-06-06",
    "offer": 17,
    "proceeds": 136,
    "year": 2024,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 8000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "MoonLake Immunotherapeutics",
    "ticker": "MLTX",
    "date": "2024-06-07",
    "offer": 54,
    "proceeds": 350,
    "year": 2024,
    "area": "Immunology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Tempus AI",
    "ticker": "TEM",
    "date": "2024-06-13",
    "offer": 37,
    "proceeds": 410.7,
    "year": 2024,
    "area": "AI/Diagnostics",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 11100000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Alumis",
    "ticker": "ALMS",
    "date": "2024-06-27",
    "offer": 16,
    "proceeds": 250,
    "year": 2024,
    "area": "Immunology/Dermatology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 15630000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Artiva Biotherapeutics",
    "ticker": "ARTV",
    "date": "2024-07-18",
    "offer": 12,
    "proceeds": 167,
    "year": 2024,
    "area": "Cell Therapy",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 13920000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "OSR Holdings",
    "ticker": "OSRX",
    "date": "2024-07-18",
    "offer": 5,
    "proceeds": 20,
    "year": 2024,
    "area": "General Biotech",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "LENSAR",
    "ticker": "LNSR",
    "date": "2024-07-19",
    "offer": 16,
    "proceeds": 100,
    "year": 2024,
    "area": "General Biotech",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "OS Therapies",
    "ticker": "OSTX",
    "date": "2024-07-31",
    "offer": 4,
    "proceeds": 6.4,
    "year": 2024,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1600000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Actuate Therapeutics",
    "ticker": "ACTU",
    "date": "2024-08-12",
    "offer": 5,
    "proceeds": 30,
    "year": 2024,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Bicara Therapeutics",
    "ticker": "BCAX",
    "date": "2024-09-12",
    "offer": 18,
    "proceeds": 362,
    "year": 2024,
    "area": "Oncology",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 20110000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "MBX Biosciences",
    "ticker": "MBX",
    "date": "2024-09-12",
    "offer": 16,
    "proceeds": 187.7,
    "year": 2024,
    "area": "Endocrine/Metabolic",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 11730000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Zenas BioPharma",
    "ticker": "ZBIO",
    "date": "2024-09-13",
    "offer": 17,
    "proceeds": 258.7,
    "year": 2024,
    "area": "Immunology",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 15220000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Impact BioMedical",
    "ticker": "IBO",
    "date": "2024-09-16",
    "offer": 5,
    "proceeds": 4.5,
    "year": 2024,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 900000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Kairos Pharma",
    "ticker": "KAPA",
    "date": "2024-09-16",
    "offer": 4,
    "proceeds": 6.2,
    "year": 2024,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1550000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "BioAge Labs",
    "ticker": "BIOA",
    "date": "2024-09-26",
    "offer": 18,
    "proceeds": 238.3,
    "year": 2024,
    "area": "Metabolic/Obesity",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 13240000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "CAMP4 Therapeutics",
    "ticker": "CAMP",
    "date": "2024-10-10",
    "offer": 11,
    "proceeds": 75,
    "year": 2024,
    "area": "Gene Therapy/RNA",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 6820000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Upstream Bio",
    "ticker": "UPB",
    "date": "2024-10-10",
    "offer": 17,
    "proceeds": 293,
    "year": 2024,
    "area": "Respiratory/Immunology",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 17240000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Septerna",
    "ticker": "SEPN",
    "date": "2024-10-24",
    "offer": 18,
    "proceeds": 331.2,
    "year": 2024,
    "area": "GPCR Therapeutics",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 18400000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Gelteq",
    "ticker": "GELS",
    "date": "2024-10-29",
    "offer": 4.5,
    "proceeds": 5.2,
    "year": 2024,
    "area": "Drug Delivery",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1160000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Invizyne Technologies",
    "ticker": "IZTC",
    "date": "2024-11-13",
    "offer": 5,
    "proceeds": 15,
    "year": 2024,
    "area": "Synthetic Biology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Jupiter Neurosciences",
    "ticker": "JUNS",
    "date": "2024-12-03",
    "offer": 4,
    "proceeds": 11,
    "year": 2024,
    "area": "Neuroscience",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Zhengye Biotechnology",
    "ticker": "ZYBT",
    "date": "2025-01-07",
    "offer": 4,
    "proceeds": 6,
    "year": 2025,
    "area": "Veterinary",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Ascentage Pharma",
    "ticker": "AAPG",
    "date": "2025-01-24",
    "offer": 17.25,
    "proceeds": 126.4,
    "year": 2025,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 7330000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Maze Therapeutics",
    "ticker": "MAZE",
    "date": "2025-01-30",
    "offer": 16,
    "proceeds": 140,
    "year": 2025,
    "area": "Nephrology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 8750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Metsera",
    "ticker": "MTSR",
    "date": "2025-01-30",
    "offer": 18,
    "proceeds": 275,
    "year": 2025,
    "area": "Metabolic/Obesity",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 15280000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Sionna Therapeutics",
    "ticker": "SION",
    "date": "2025-02-06",
    "offer": 18,
    "proceeds": 191,
    "year": 2025,
    "area": "Respiratory/CF",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 10610000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Aardvark Therapeutics",
    "ticker": "AARD",
    "date": "2025-02-12",
    "offer": 16,
    "proceeds": 94.2,
    "year": 2025,
    "area": "Metabolic/Obesity",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 5890000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Wellgistics Health",
    "ticker": "WGRX",
    "date": "2025-02-21",
    "offer": 5,
    "proceeds": 10,
    "year": 2025,
    "area": "Pharma Distribution",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Advanced Biomed",
    "ticker": "ADVB",
    "date": "2025-03-06",
    "offer": 4,
    "proceeds": 6.56,
    "year": 2025,
    "area": "Diagnostics",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 1640000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Cuprina Holdings",
    "ticker": "CUPR",
    "date": "2025-04-11",
    "offer": 4,
    "proceeds": 12,
    "year": 2025,
    "area": "Wound Care",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Apimeds Pharmaceuticals",
    "ticker": "APUS",
    "date": "2025-05-09",
    "offer": 5,
    "proceeds": 13.5,
    "year": 2025,
    "area": "Immunology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2700000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Jyong Biotech",
    "ticker": "MENS",
    "date": "2025-06-18",
    "offer": 7.5,
    "proceeds": 20,
    "year": 2025,
    "area": "General Biotech",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": null,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Nasus Pharma",
    "ticker": "NSRX",
    "date": "2025-08-13",
    "offer": 5,
    "proceeds": 10,
    "year": 2025,
    "area": "ENT/Nasal",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 2000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Curanex Pharmaceuticals",
    "ticker": "CURX",
    "date": "2025-08-26",
    "offer": 4,
    "proceeds": 15,
    "year": 2025,
    "area": "Oncology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 3750000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "LB Pharmaceuticals",
    "ticker": "LBRX",
    "date": "2025-09-11",
    "offer": 15,
    "proceeds": 285,
    "year": 2025,
    "area": "Neuroscience/Psych",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 19000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "MapLight Therapeutics",
    "ticker": "MPLT",
    "date": "2025-10-27",
    "offer": 17,
    "proceeds": 296.3,
    "year": 2025,
    "area": "Neuroscience/Psych",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 17430000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Evommune",
    "ticker": "EVMN",
    "date": "2025-11-05",
    "offer": 15,
    "proceeds": 150,
    "year": 2025,
    "area": "Immunology/Derm",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Aktis Oncology",
    "ticker": "AKTS",
    "date": "2026-01-09",
    "offer": 18,
    "proceeds": 318,
    "year": 2026,
    "area": "Oncology/Radiopharm",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 17670000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Eikon Therapeutics",
    "ticker": "EIKN",
    "date": "2026-02-05",
    "offer": 20,
    "proceeds": 381,
    "year": 2026,
    "area": "Oncology/Immunology",
    "pricing": "Above",
    "status": "Upsized",
    "ipo_status": "active",
    "shares_offered": 19050000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "AgomAb Therapeutics",
    "ticker": "AGMB",
    "date": "2026-02-06",
    "offer": 16,
    "proceeds": 200,
    "year": 2026,
    "area": "GI/Fibrosis",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 12500000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "SpyGlass Pharma",
    "ticker": "SGP",
    "date": "2026-02-06",
    "offer": 15,
    "proceeds": 150,
    "year": 2026,
    "area": "Ophthalmology",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 10000000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  },
  {
    "company": "Veradermics",
    "ticker": "MANE",
    "date": "2026-02-06",
    "offer": 17,
    "proceeds": 256.3,
    "year": 2026,
    "area": "Dermatology/Hair Loss",
    "pricing": "At",
    "status": "Priced",
    "ipo_status": "active",
    "shares_offered": 15080000,
    "range_low": null,
    "range_high": null,
    "first_day_close": null
  }
]